From: Protein coalitions in a core mammalian biochemical network linked by rapidly evolving proteins
Gene | OMIM Code | Disease |
---|---|---|
GCK | 125851 | MODY, type II, |
 | 125853 | Insulin resistance, susceptibility to, |
 | 602485 | Hyperinsulinemic hypoglycemia, familial, 3 |
 | 606176 | Diabetes, permanent neonatal |
FBa | 229600 | Fructose intolerance |
FBc | 611881 | Glycogen storage disease XII |
PGP2 | 261670 | Glycogen storage disease X |
PK | 102900 | Adenosine triphosphate, elevated, of erythrocytes |
 | 266200 | Pyruvate kinase deficiency |
PDCa | 308930 | Leigh syndrome, X-linked |
 | 312170 | Pyruvate dehydrogenase deficiency |
PDCb | 312170 | Pyruvate dehydrogenase deficiency |
OGDC | 203740 | Alpha-ketoglutarate dehydrogenase deficiency |
SCSa | 245400 | Lactic acidosis, fatal infantile |
SDHa | 115310 | Paraganglioma, familial chromaffin, 4 |
 | 171300 | Pheochromocytoma, modifier of |
 | 606864 | Paraganglioma and gastric stromal sarcoma |
 | 612359 | Cowden-like syndrome |
SDHb | 252011 | Mitochondrial respiratory chain complex II deficiency |
 | 256000 | Leigh syndrome, due to Cox deficiency |
FM | 150800 | Multiple cutaneous and uterine leiomyomata |
 | 605839 | Leiomyomatosis and renal cell cancer |
 | 606812 | Fumarase deficiency |
MT-ND1 | 252010 | Mitochondrial complex I deficiency |
MT-ND2 | 256000 | Leigh syndrome, due to Cox deficiency |
UQCRQ | 124000 | Mitochondrial complex III deficiency |
Cox6B1 | 220110 | Mitochondrial complex IV deficiency |
Cox2 | 220110 | Mitochondrial complex IV deficiency |
Cox1 | 220110 | Mitochondrial complex IV deficiency |
GUT2P | 125853 | Insulin resistance, susceptibility to |
IDHcc | 137800 | Glioblastoma, susceptibility to |
PC | 266150 | Pyruvate carboxylase deficiency |
ETF-QO | 231680 | Glutaricaciduria, type IIC |
SOD2c | 105400 | Amyotrophic lateral sclerosis, susceptibility to |
SOD2 m | 612634 | Microvascular complications of diabetes, susceptibility to |